Advertisement
Advertisement
U.S. markets open in 7 hours 3 minutes
Advertisement
Advertisement
Advertisement
Advertisement

NovaBay Pharmaceuticals, Inc. (NBY)

NYSE American - Nasdaq Real Time Price. Currency in USD
Add to watchlist
0.3438+0.0006 (+0.17%)
At close: 03:59PM EST
0.3500 +0.01 (+1.80%)
After hours: 05:33PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Downside Breakout

Downside Breakout

Previous Close0.3432
Open0.3500
Bid0.0000 x 1100
Ask0.0000 x 900
Day's Range0.3340 - 0.3540
52 Week Range0.3300 - 1.7900
Volume538,246
Avg. Volume950,145
Market Cap15.457M
Beta (5Y Monthly)3.48
PE Ratio (TTM)N/A
EPS (TTM)-0.1730
Earnings DateMar 23, 2022 - Mar 28, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.10
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for NBY

Learn more
View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • NovaBay Pharmaceuticals, Inc.
    Weekly Stock ListThis is among our most-important themes for 2022, and stretches across industries. We think companies that raise their dividends consistently at a double-digit rate are sending off three important signals amid all the recent market volatility: 1) the company's balance sheet is strong enough to pay a dividend; 2) management is focused on providing shareholder returns; and 3) management is confident enough in the near-term outlook to raise the payout aggressively. This third factor is especially important as the pandemic upends the nation's recent record of long-term economic growth. Here are 12 stocks that meet our double-digit dividend test and are on the Argus BUY list. They are also holdings in our Dividend Growth Separately Managed Account and in the Dividend Growers Total Return Trust, sponsored by SmartTrust.
    Rating
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more
Advertisement
Advertisement